30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Celldex Therapeutics Inc (CLDX)

Track

Stock chart
Ticker: CLDX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Jimenez Freddy A.
SVP & GENERAL COUNSEL
1 sale — total 121,210 USD
Sale 4 Dec 2025
Value US$4,848,147.01 | Price 95.97 | Shares 80,552
Proposed sale 4 Dec 2025
Value US$1,984,361.79 | Price 316.07 | Shares 75,837
Sale 13 Nov 2025
Value US$1,183,176.65 | Price 24.00 | Shares 49,298
Proposed sale 13 Nov 2025
Value US$1,183,176.65 | Price 24.00 | Shares 49,298
Sale 13 Aug 2025
Value US$10,928.45 | Price 25.42 | Shares 430
Planned sale 13 Aug 2025
Value US$8,167.46 | Price 23.95 | Shares 341
Planned buy 11 Nov 2024
Value US$308,430.00 | Price 26.82 | Shares 11,500
Sale 14 Jun 2024
Value US$1,045,962.00 | Price 34.87 | Shares 30,000
Proposed sale 14 Jun 2024
Value US$1,020,000.00 | Price 34.00 | Shares 30,000
Sale 14 Jun 2024
Value US$608,314.67 | Price 35.42 | Shares 17,172
Proposed sale 14 Jun 2024
Value US$583,848.00 | Price 34.00 | Shares 17,172
Sale 7 Jun 2024
Value US$1,586,844.00 | Price 35.26 | Shares 45,000
Proposed sale 7 Jun 2024
Value US$1,586,842.65 | Price 35.26 | Shares 45,000
Sale 7 Jun 2024
Value US$525,873.00 | Price 35.06 | Shares 15,000
Proposed sale 7 Jun 2024
Value US$510,000.00 | Price 34.00 | Shares 15,000
Sale 3 Jun 2024
Value US$654,694.75 | Price 33.99 | Shares 19,264
Sale 3 Jun 2024
Value US$924,658.11 | Price 33.53 | Shares 27,580
Proposed sale 3 Jun 2024
Value US$1,499,008.00 | Price 32.00 | Shares 46,844
Sale 3 Jun 2024
Value US$269,002.40 | Price 33.60 | Shares 8,006
Proposed sale 3 Jun 2024
Value US$269,002.40 | Price 33.60 | Shares 8,006
Sale 3 Jun 2024
Value US$1,964,087.67 | Price 33.65 | Shares 58,369
Sale 30 May 2024
Value US$1,298,383.78 | Price 33.64 | Shares 38,597
Proposed sale 30 May 2024
Value US$144,003.76 | Price 3.73 | Shares 38,597
Sale 30 May 2024
Value US$703,334.15 | Price 33.73 | Shares 20,853
Proposed sale 30 May 2024
Value US$703,334.25 | Price 33.73 | Shares 20,853
Sale 30 May 2024
Value US$1,319,156.33 | Price 34.07 | Shares 38,719
Proposed sale 30 May 2024
Value US$3,526,236.16 | Price 36.32 | Shares 97,088
Sale 30 May 2024
Value US$1,191,774.50 | Price 34.05 | Shares 35,000
Proposed sale 30 May 2024
Value US$1,191,770.85 | Price 34.05 | Shares 35,000
Sale 7 Dec 2022
Value US$622,611.14 | Price 36.93 | Shares 16,860
Sale 18 Aug 2022
Value US$49,289.07 | Price 36.38 | Shares 1,355
Sale 17 Aug 2022
Value US$708,715.20 | Price 37.30 | Shares 19,000
Sale 17 Aug 2022
Value US$1,150,221.27 | Price 36.73 | Shares 31,312
Sale 15 Aug 2022
Value US$4,519,572.00 | Price 37.66 | Shares 120,000
Sale 15 Aug 2022
Value US$578,048.00 | Price 37.71 | Shares 15,328
Sale 12 Aug 2022
Value US$42,271.75 | Price 34.62 | Shares 1,221
Sale 12 Aug 2022
Value US$73,052.68 | Price 35.38 | Shares 2,065
Sale 12 Aug 2022
Value US$524,304.24 | Price 36.76 | Shares 14,261
Sale 11 Aug 2022
Value US$90,856.42 | Price 37.04 | Shares 2,453
Planned sale 8 Dec 2021
Value US$292,920.00 | Price 40.00 | Shares 7,323
Planned sale 8 Dec 2021
Value US$24,000.00 | Price 40.00 | Shares 600
Planned sale 8 Dec 2021
Value US$160,000.00 | Price 40.00 | Shares 4,000
Planned sale 15 Nov 2021
Value US$86,569.16 | Price 42.27 | Shares 2,048
Planned sale 15 Nov 2021
Value US$327,314.20 | Price 43.92 | Shares 7,452
Sale 12 Nov 2021
Value US$197,529.06 | Price 42.94 | Shares 4,600
Planned sale 1 Nov 2021
Value US$49,481.42 | Price 41.62 | Shares 1,189
Planned sale 1 Nov 2021
Value US$25,867.80 | Price 43.11 | Shares 600
Planned sale 1 Nov 2021
Value US$111,525.25 | Price 44.12 | Shares 2,528
Planned sale 1 Nov 2021
Value US$88,232.28 | Price 41.62 | Shares 2,120
Planned sale 1 Nov 2021
Value US$38,797.96 | Price 43.06 | Shares 901
Planned sale 1 Nov 2021
Value US$189,774.13 | Price 44.11 | Shares 4,302
Planned sale 1 Nov 2021
Value US$25,026.00 | Price 41.71 | Shares 600
Sale 14 Dec 2020
Value US$174,435.94 | Price 18.61 | Shares 9,375
Sale 14 Dec 2020
Value US$213,174.67 | Price 18.61 | Shares 11,457
Buy 11 Jun 2020
Value US$10,003.95 | Price 4.73 | Shares 2,115
Buy 10 Jun 2020
Value US$5,071.50 | Price 4.83 | Shares 1,050
Buy 9 Jun 2020
Value US$14,954.00 | Price 2.99 | Shares 5,000
Buy 9 Jun 2020
Value US$24,915.00 | Price 3.00 | Shares 8,305
Planned buy 9 Jun 2020
Value US$29,737.50 | Price 3.05 | Shares 9,750
Planned buy 9 Jun 2020
Value US$45,900.00 | Price 3.06 | Shares 15,000
Buy 9 Jun 2020
Value US$3,005.00 | Price 3.01 | Shares 1,000
Buy 24 Aug 2018
Value US$19,200.00 | Price 0.48 | Shares 40,000
Buy 15 Jun 2018
Value US$9,782.85 | Price 0.59 | Shares 16,500
Buy 2 Sep 2016
Value US$9,960.00 | Price 3.32 | Shares 3,000
Planned sale 23 Nov 2015
Value US$450,000.00 | Price 18.00 | Shares 25,000
Buy 25 Aug 2015
Value US$70,000.00 | Price 14.00 | Shares 5,000
Buy 20 Aug 2015
Value US$75,000.00 | Price 15.00 | Shares 5,000
Buy 18 Aug 2015
Value US$39,900.00 | Price 15.96 | Shares 2,500
Buy 18 Aug 2015
Value US$35,068.00 | Price 15.94 | Shares 2,200
Buy 18 Aug 2015
Value US$4,779.00 | Price 15.93 | Shares 300
Buy 13 Aug 2015
Value US$82,950.00 | Price 16.59 | Shares 5,000
Planned sale 15 Jun 2015
Value US$614,752.50 | Price 24.59 | Shares 25,000
Sale 6 Dec 2013
Value US$434,336.00 | Price 24.50 | Shares 17,728
Sale 6 Dec 2013
Value US$434,336.00 | Price 24.50 | Shares 17,728
Sale 6 Dec 2013
Value US$434,336.00 | Price 24.50 | Shares 17,728
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-08 2025-12-04 S Sale
2.3
Jimenez Freddy A.

SVP & GENERAL COUNSEL

Officer
80,552 +24.6%
95.97
US$4,848,147 		80,552 +24.6% 95.97 US$4,848,147
2025-12-04 2025-12-04 PrS Proposed sale
2.3
FREDDY A JIMENEZ

Officer

Officer
75,837
316.07
US$1,984,362 		75,837 316.07 US$1,984,362
2025-11-17 2025-11-13 S Sale
2.2
Wright Richard M.
17,828 +36.1%
129.29
US$3,997,656 		17,828 +36.1% 129.29 US$3,997,656
2025-11-13 2025-11-13 PrS Proposed sale
2.2
RICHARD M WRIGHT

Officer

Officer
49,298
24.00
US$1,183,177 		49,298 24.00 US$1,183,177
2025-08-15 2025-08-13 S Sale
2.3
Jimenez Freddy A.

SVP & GENERAL COUNSEL

Officer
430 -1.2%
25.42
US$10,928 		430 -1.2% 25.42 US$10,928
2025-08-15 2025-08-13 PlS Planned sale
2.3
Jimenez Freddy A.

SVP & GENERAL COUNSEL

Officer
341 -1.0%
23.95
US$8,167 		341 -1.0% 23.95 US$8,167
2024-11-12 2024-11-11 PP Planned purchase
2.4
Marucci Anthony S

PRESIDENT & CEO

Executive Director
11,500 +40.0%
26.82
US$308,430 		11,500 +40.0% 26.82 US$308,430
2024-06-18 2024-06-14 S Sale
1.7
Crowley Elizabeth

SR. VP & CPDO

Officer
30,000 -76.8%
34.87
US$1,045,962 		30,000 -76.8% 34.87 US$1,045,962
2024-06-18 2024-06-14 S Sale
2.1
Martin Samuel Bates

SVP AND CFO

Officer
17,172 -37.9%
35.42
US$608,315 		17,172 -37.9% 35.42 US$608,315
2024-06-14 2024-06-14 PrS Proposed sale
1.7
Crowley Elizabeth

Officer

Officer
30,000
34.00
US$1,020,000 		30,000 34.00 US$1,020,000
2024-06-14 2024-06-14 PrS Proposed sale
2.1
Martin Samuel Bates

Officer

Officer
17,172
34.00
US$583,848 		17,172 34.00 US$583,848
2024-06-11 2024-06-07 S Sale
3.1
Young Diane C.

SVP, CHIEF MEDICAL OFFICER

Officer
45,000 -95.5%
35.26
US$1,586,844 		45,000 -95.5% 35.26 US$1,586,844
2024-06-11 2024-06-07 S Sale
1.7
Crowley Elizabeth

SR. VP & CPDO

Officer
15,000 -62.3%
35.06
US$525,873 		15,000 -62.3% 35.06 US$525,873
2024-06-07 2024-06-07 PrS Proposed sale
3.1
Young Diane C.

Officer

Officer
45,000
35.26
US$1,586,843 		45,000 35.26 US$1,586,843
2024-06-07 2024-06-07 PrS Proposed sale
1.7
Crowley Elizabeth

Officer

Officer
15,000
34.00
US$510,000 		15,000 34.00 US$510,000
2024-06-05 2024-06-03 S Sale
2.2
Wright Richard M.

SR. VP & CCO

Officer
19,264 -48.0%
33.99
US$654,695 		19,264 -48.0% 33.99 US$654,695
2024-06-05 2024-06-03 S Sale
2.2
Wright Richard M.

SR. VP & CCO

Officer
27,580 -40.8%
33.53
US$924,658 		27,580 -40.8% 33.53 US$924,658
2024-06-05 2024-06-03 S Sale
2.3
Jimenez Freddy A.

SVP & GENERAL COUNSEL

Officer
8,006 -23.6%
33.60
US$269,002 		8,006 -23.6% 33.60 US$269,002
2024-06-05 2024-06-03 S Sale
2.7
Heath-Chiozzi Margo

SVP OF REGULATORY AFFAIRS

Officer
58,369 -81.3%
33.65
US$1,964,088 		58,369 -81.3% 33.65 US$1,964,088
2024-06-03 2024-06-03 PrS Proposed sale
2.3
Jimenez Freddy A.

Officer

Officer
8,006
33.60
US$269,002 		8,006 33.60 US$269,002
2024-06-03 2024-06-03 PrS Proposed sale
2.2
Wright Richard M.

Officer

Officer
46,844
32.00
US$1,499,008 		46,844 32.00 US$1,499,008
2024-06-03 2024-05-30 S Sale
1.7
Crowley Elizabeth

SR. VP & CPDO

Officer
38,597 -81.0%
33.64
US$1,298,384 		38,597 -81.0% 33.64 US$1,298,384
2024-06-03 2024-05-30 S Sale
3.0
Cavanaugh Sarah

SVP OF CORP AFFAIRS & ADMIN.

Officer
20,853 -91.8%
33.73
US$703,334 		20,853 -91.8% 33.73 US$703,334
2024-06-03 2024-05-30 S Sale
2.7
Heath-Chiozzi Margo

SVP OF REGULATORY AFFAIRS

Officer
38,719 -84.5%
34.07
US$1,319,156 		38,719 -84.5% 34.07 US$1,319,156
2024-06-03 2024-05-30 S Sale
2.1
Martin Samuel Bates

SVP AND CFO

Officer
35,000 -58.2%
34.05
US$1,191,774 		35,000 -58.2% 34.05 US$1,191,774
2024-05-30 2024-05-30 PrS Proposed sale
3.0
Cavanaugh Sarah

Officer

Officer
20,853
33.73
US$703,334 		20,853 33.73 US$703,334
2024-05-30 2024-05-30 PrS Proposed sale
2.1
Martin Samuel Bates

Officer

Officer
35,000
34.05
US$1,191,771 		35,000 34.05 US$1,191,771
2024-05-30 2024-05-30 PrS Proposed sale
1.7
Crowley Elizabeth

Officer

Officer
38,597
3.73
US$144,004 		38,597 3.73 US$144,004
2024-05-30 2024-05-30 PrS Proposed sale
2.7
Heath-Chiozzi Margo

Director

Non-Executive Director
97,088
36.32
US$3,526,236 		97,088 36.32 US$3,526,236
2022-12-09 2022-12-07 S Sale
2.7
KELER TIBOR

EXECUTIVE VP & CSO

Officer
16,860 -69.6%
36.93
US$622,611 		16,860 -69.6% 36.93 US$622,611
2022-08-19 2022-08-18 S Sale
3.0
Cavanaugh Sarah

SVP OF CORP AFFAIRS & ADMIN.

Officer
1,355 -51.3%
36.38
US$49,289 		1,355 -51.3% 36.38 US$49,289
2022-08-19 2022-08-17 S Sale
3.1
Young Diane C.

SVP, CHIEF MEDICAL OFFICER

Officer
19,000 -90.0%
37.30
US$708,715 		19,000 -90.0% 37.30 US$708,715
2022-08-19 2022-08-17 S Sale
3.0
Cavanaugh Sarah

SVP OF CORP AFFAIRS & ADMIN.

Officer
31,312 -96.1%
36.73
US$1,150,221 		31,312 -96.1% 36.73 US$1,150,221
2022-08-17 2022-08-15 S Sale
2.4
Marucci Anthony S

PRESIDENT & CEO

Executive Director
120,000 -81.3%
37.66
US$4,519,572 		120,000 -81.3% 37.66 US$4,519,572
2022-08-17 2022-08-15 S Sale
2.2
Wright Richard M.

SR. VP & CCO

Officer
15,328 -98.7%
37.71
US$578,048 		15,328 -98.7% 37.71 US$578,048
2022-08-15 2022-08-12 S Sale
2.1
Martin Samuel Bates

SVP AND CFO

Officer
1,221 -4.8%
34.62
US$42,272 		1,221 -4.8% 34.62 US$42,272
2022-08-15 2022-08-12 S Sale
2.1
Martin Samuel Bates

SVP AND CFO

Officer
2,065 -7.5%
35.38
US$73,053 		2,065 -7.5% 35.38 US$73,053
2022-08-15 2022-08-12 S Sale
2.1
Martin Samuel Bates

SVP AND CFO

Officer
14,261 -34.0%
36.76
US$524,304 		14,261 -34.0% 36.76 US$524,304
2022-08-15 2022-08-11 S Sale
2.1
Martin Samuel Bates

SVP AND CFO

Officer
2,453 -9.1%
37.04
US$90,856 		2,453 -9.1% 37.04 US$90,856
2021-12-10 2021-12-08 PlS Planned sale
3.0
Cavanaugh Sarah

SVP of Corp Affairs & Admin.

Officer
7,323 -94.7%
40.00
US$292,920 		7,323 -94.7% 40.00 US$292,920
2021-12-10 2021-12-08 PlS Planned sale
2.7
Heath-Chiozzi Margo

SVP of Regulatory Affairs

Officer
600 -5.1%
40.00
US$24,000 		600 -5.1% 40.00 US$24,000
2021-12-10 2021-12-08 PlS Planned sale
1.7
Crowley Elizabeth

Sr. VP &CPDO

Officer
4,000 -45.8%
40.00
US$160,000 		4,000 -45.8% 40.00 US$160,000
2021-11-17 2021-11-15 PlS Planned sale
2.1
Martin Samuel Bates

SVP and CFO

Officer
2,048 -7.1%
42.27
US$86,569 		2,048 -7.1% 42.27 US$86,569
2021-11-17 2021-11-15 PlS Planned sale
2.1
Martin Samuel Bates

SVP and CFO

Officer
7,452 -20.5%
43.92
US$327,314 		7,452 -20.5% 43.92 US$327,314
2021-11-16 2021-11-12 S Sale
3.1
Young Diane C.

SVP, Chief Medical Officer

Officer
4,600 -68.5%
42.94
US$197,529 		4,600 -68.5% 42.94 US$197,529
2021-11-03 2021-11-01 PlS Planned sale
1.7
Crowley Elizabeth

Sr. VP &CPDO

Officer
1,189 -20.1%
41.62
US$49,481 		1,189 -20.1% 41.62 US$49,481
2021-11-03 2021-11-01 PlS Planned sale
1.7
Crowley Elizabeth

Sr. VP &CPDO

Officer
600 -9.2%
43.11
US$25,868 		600 -9.2% 43.11 US$25,868
2021-11-03 2021-11-01 PlS Planned sale
1.7
Crowley Elizabeth

Sr. VP &CPDO

Officer
2,528 -28.0%
44.12
US$111,525 		2,528 -28.0% 44.12 US$111,525
2021-11-03 2021-11-01 PlS Planned sale
3.0
Cavanaugh Sarah

SVP of Corp Affairs & Admin.

Officer
2,120 -83.9%
41.62
US$88,232 		2,120 -83.9% 41.62 US$88,232
2021-11-03 2021-11-01 PlS Planned sale
3.0
Cavanaugh Sarah

SVP of Corp Affairs & Admin.

Officer
901 -26.3%
43.06
US$38,798 		901 -26.3% 43.06 US$38,798
2021-11-03 2021-11-01 PlS Planned sale
3.0
Cavanaugh Sarah

SVP of Corp Affairs & Admin.

Officer
4,302 -55.6%
44.11
US$189,774 		4,302 -55.6% 44.11 US$189,774
2021-11-03 2021-11-01 PlS Planned sale
2.7
Heath-Chiozzi Margo

SVP of Regulatory Affairs

Officer
600 -5.1%
41.71
US$25,026 		600 -5.1% 41.71 US$25,026
2020-12-16 2020-12-14 S Sale
2.2
Wright Richard M.

Sr. VP & CCO

Officer
9,375 -97.8%
18.61
US$174,436 		9,375 -97.8% 18.61 US$174,436
2020-12-16 2020-12-14 S Sale
2.2
Wright Richard M.

Sr. VP & CCO

Officer
11,457 -98.2%
18.61
US$213,175 		11,457 -98.2% 18.61 US$213,175
2020-06-12 2020-06-11 B Purchase
3.1
Young Diane C.

SVP, Chief Medical Officer

Officer
2,115 +inf%
4.73
US$10,004 		2,115 +inf% 4.73 US$10,004
2020-06-11 2020-06-10 B Purchase
3.0
Cavanaugh Sarah

SVP of Corp Affairs & Admin.

Officer
1,050 +331.2%
4.83
US$5,072 		1,050 +331.2% 4.83 US$5,072
2020-06-10 2020-06-09 B Purchase
2.7
KELER TIBOR

Executive VP & CSO

Officer
5,000 +212.1%
2.99
US$14,954 		5,000 +212.1% 2.99 US$14,954
2020-06-10 2020-06-09 B Purchase
3.8
MARINO JAMES J
Non-Executive Director
8,305 +188.8%
3.00
US$24,915 		8,305 +188.8% 3.00 US$24,915
2020-06-10 2020-06-09 PP Planned purchase
2.1
Martin Samuel Bates

SVP and CFO

Officer
9,750 +989.8%
3.05
US$29,738 		9,750 +989.8% 3.05 US$29,738
2020-06-10 2020-06-09 PP Planned purchase
2.4
Marucci Anthony S

President & CEO

Executive Director
15,000 +338.0%
3.06
US$45,900 		15,000 +338.0% 3.06 US$45,900
2020-06-10 2020-06-09 B Purchase
2.7
Heath-Chiozzi Margo

SVP of Regulatory Affairs

Officer
1,000 +inf%
3.01
US$3,005 		1,000 +inf% 3.01 US$3,005
2018-08-28 2018-08-24 B Purchase MARINO JAMES J Non-Executive Director
40,000 +153.9%
0.48
US$19,200 		40,000 +153.9% 0.48 US$19,200
2018-06-18 2018-06-15 B Purchase KELER TIBOR

Executive VP & CSO

Officer
16,500 +87.4%
0.59
US$9,783 		16,500 +87.4% 0.59 US$9,783
2016-09-06 2016-09-02 B Purchase KELER TIBOR

Executive VP & CSO

Officer
3,000 +18.9%
3.32
US$9,960 		3,000 +18.9% 3.32 US$9,960
2015-11-25 2015-11-23 PlS Planned sale CATLIN AVERY W

Sr. VP & CFO

Officer
25,000 -41.6%
18.00
US$450,000 		25,000 -41.6% 18.00 US$450,000
2015-08-26 2015-08-25 B Purchase ELLBERGER LARRY Non-Executive Director
5,000 +10.3%
14.00
US$70,000 		5,000 +10.3% 14.00 US$70,000
2015-08-21 2015-08-20 B Purchase ELLBERGER LARRY Non-Executive Director
5,000 +11.5%
15.00
US$75,000 		5,000 +11.5% 15.00 US$75,000
2015-08-19 2015-08-18 B Purchase ELLBERGER LARRY Non-Executive Director
2,500 +6.1%
15.96
US$39,900 		2,500 +6.1% 15.96 US$39,900
2015-08-19 2015-08-18 B Purchase ELLBERGER LARRY Non-Executive Director
2,200 +5.7%
15.94
US$35,068 		2,200 +5.7% 15.94 US$35,068
2015-08-19 2015-08-18 B Purchase ELLBERGER LARRY Non-Executive Director
300 +0.8%
15.93
US$4,779 		300 +0.8% 15.93 US$4,779
2015-08-14 2015-08-13 B Purchase ELLBERGER LARRY Non-Executive Director
5,000 +14.9%
16.59
US$82,950 		5,000 +14.9% 16.59 US$82,950
2015-06-16 2015-06-15 PlS Planned sale CATLIN AVERY W

Sr. VP & CFO

Officer
25,000 -50.4%
24.59
US$614,752 		25,000 -50.4% 24.59 US$614,752
2013-12-10 2013-12-06 S Sale LIPTON KAREN SHOOS Non-Executive Director
17,728 -57.1%
24.50
US$434,336 		17,728 -57.1% 24.50 US$434,336
2013-12-10 2013-12-06 S Sale PENNER HARRY JR Non-Executive Director
17,728 -56.9%
24.50
US$434,336 		17,728 -56.9% 24.50 US$434,336
2013-12-10 2013-12-06 S Sale ELLBERGER LARRY Non-Executive Director
17,728 -41.5%
24.50
US$434,336 		17,728 -41.5% 24.50 US$434,336
Explore more

More insider trading research around Celldex Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America